Podcast Episodes
Back to Search
Ep. 366 - Europe's need for speed: Bio€quity takeaways
Season 7 Episode 366
China’s speed in generating first-in-human data has catalyzed a race across the globe to reshape regulatory requirements to compete. BioCentury’s ana…
3 months, 3 weeks ago
Ep. 365 - Thin ice for Makary, redosing AAVs
Season 7 Episode 365
Marty Makary’s hold on the top job at FDA is slipping, with White House leaks about President Donald Trump’s displeasure with the FDA commissioner sh…
3 months, 4 weeks ago
Ep. 364 - UCB’s Candid buy, Grand Rounds and leukodystrophies
Season 7 Episode 364
UCB is the latest biopharma player to consummate a multibillion-dollar deal amid a surge in biotech M&A activity, acquiring Ken Song’s Candid Therape…
4 months ago
Ep. 363 - New targets at AACR, biopharma deals, Kurma fund
Season 7 Episode 653
More than 175 new oncology targets surfaced at this year’s American Association for Cancer Research annual meeting in San Diego, with the focus on ne…
4 months, 1 week ago
Ep. 362 - AACR: Data and de-risking
Season 7 Episode 362
Bispecific antibodies and dual-payload antibody-drug conjugates were in the spotlight at this year’s American Association for Cancer Research meeting…
4 months, 2 weeks ago
Ep. 361 - Kelonia, Kailera, pyschedelics and T cell engagers
Season 7 Episode 361
The past week has delivered the largest M&A deal ever for a private, venture-backed biopharma, the second-largest follow-on ever for a NASDAQ-traded …
4 months, 2 weeks ago
Ep. 360 - FDA’s FIH plans. Plus: billion-dollar deals, funds
Season 7 Episode 360
A pathway proposed by FDA to cut the time it takes biopharma companies to get to first-in-human trials is more ambitious than similar policies in Aus…
4 months, 3 weeks ago
Ep. 359 - 2Q markets preview, tariffs and biotech takeouts
Season 7 Episode 359
Biotech has been resilient as the financial markets teeter under global volatility. For now, M&A and financings, if not IPOs, are continuing, but wil…
5 months ago
Ep. 358 - Europe's biotech challenge
Season 7 Episode 358
Biotech innovators around the world are finding speed to be the driver for investment and partnering — speed to early human data and speed to de-risk…
5 months, 1 week ago
Ep. 357 - Deal-O-rama, Gilead and Tallon's U.K. vision
Season 7 Episode 357
A flurry of deals, several with sizable upfront payments, has energized the biotech sector in March. On the latest BioCentury This Week podcast, BioC…
5 months, 1 week ago